Wilmington Savings Fund Society FSB Invests $40,000 in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Wilmington Savings Fund Society FSB purchased a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 2,819 shares of the company’s stock, valued at approximately $40,000.

A number of other hedge funds have also bought and sold shares of TAK. EverSource Wealth Advisors LLC lifted its holdings in Takeda Pharmaceutical by 38.6% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock worth $43,000 after buying an additional 859 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in Takeda Pharmaceutical by 416.0% during the third quarter. BNP Paribas Financial Markets now owns 3,220 shares of the company’s stock worth $46,000 after purchasing an additional 2,596 shares during the last quarter. Smithfield Trust Co boosted its holdings in Takeda Pharmaceutical by 76.9% in the third quarter. Smithfield Trust Co now owns 3,428 shares of the company’s stock worth $49,000 after purchasing an additional 1,490 shares during the period. Erste Asset Management GmbH bought a new stake in Takeda Pharmaceutical during the third quarter valued at $52,000. Finally, Headlands Technologies LLC bought a new stake in Takeda Pharmaceutical during the second quarter valued at $59,000. 9.17% of the stock is currently owned by institutional investors and hedge funds.

Takeda Pharmaceutical Trading Up 0.7 %

Takeda Pharmaceutical stock opened at $13.10 on Monday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28. Takeda Pharmaceutical Company Limited has a 1 year low of $12.57 and a 1 year high of $15.08. The firm’s 50-day moving average is $13.70 and its 200-day moving average is $13.88. The company has a market cap of $41.68 billion, a P/E ratio of 22.59, a PEG ratio of 0.25 and a beta of 0.51.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.